Xenetic Biosciences Stock Probability of Future Stock Price Finishing Over 18.62
| XBIO Stock | USD 4.35 0.02 0.46% |
Xenetic |
Xenetic Biosciences Target Price Odds to finish over 18.62
The tendency of Xenetic Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 18.62 or more in 90 days |
| 4.35 | 90 days | 18.62 | close to zero percent |
Based on a normal probability distribution, the odds of Xenetic Biosciences to move over $ 18.62 or more in 90 days from now is close to zero percent (This Xenetic Biosciences probability density function shows the probability of Xenetic Stock to fall within a particular range of prices over 90 days) . Probability of Xenetic Biosciences price to stay between its current price of $ 4.35 and $ 18.62 at the end of the 90-day period is about 8.74 .
Given the investment horizon of 90 days Xenetic Biosciences has a beta of 0.0281. This entails as returns on the market go up, Xenetic Biosciences average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Xenetic Biosciences will be expected to be much smaller as well. Additionally Xenetic Biosciences has an alpha of 0.3379, implying that it can generate a 0.34 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Xenetic Biosciences Price Density |
| Price |
Predictive Modules for Xenetic Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Xenetic Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Xenetic Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Xenetic Biosciences is not an exception. The market had few large corrections towards the Xenetic Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Xenetic Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Xenetic Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.34 | |
β | Beta against Dow Jones | 0.03 | |
σ | Overall volatility | 0.28 | |
Ir | Information ratio | 0.05 |
Xenetic Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Xenetic Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Xenetic Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Xenetic Biosciences had very high historical volatility over the last 90 days | |
| Xenetic Biosciences has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 2.54 M. Net Loss for the year was (4.13 M) with profit before overhead, payroll, taxes, and interest of 1.16 M. | |
| Xenetic Biosciences currently holds about 14.93 M in cash with (4.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.04. | |
| Xenetic Biosciences has a poor financial position based on the latest SEC disclosures | |
| Roughly 19.0% of the company outstanding shares are owned by insiders | |
| Latest headline from finance.yahoo.com: Xenetic Biosciences, Inc. Enters into Clinical Trial Services Agreement with PeriNess Ltd. to Accelerate Development of DNase I Oncology Program |
Xenetic Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Xenetic Stock often depends not only on the future outlook of the current and potential Xenetic Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Xenetic Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.5 M | |
| Cash And Short Term Investments | 9 M |
Xenetic Biosciences Technical Analysis
Xenetic Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Xenetic Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Xenetic Biosciences. In general, you should focus on analyzing Xenetic Stock price patterns and their correlations with different microeconomic environments and drivers.
Xenetic Biosciences Predictive Forecast Models
Xenetic Biosciences' time-series forecasting models is one of many Xenetic Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Xenetic Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Xenetic Biosciences
Checking the ongoing alerts about Xenetic Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Xenetic Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Xenetic Biosciences had very high historical volatility over the last 90 days | |
| Xenetic Biosciences has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 2.54 M. Net Loss for the year was (4.13 M) with profit before overhead, payroll, taxes, and interest of 1.16 M. | |
| Xenetic Biosciences currently holds about 14.93 M in cash with (4.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.04. | |
| Xenetic Biosciences has a poor financial position based on the latest SEC disclosures | |
| Roughly 19.0% of the company outstanding shares are owned by insiders | |
| Latest headline from finance.yahoo.com: Xenetic Biosciences, Inc. Enters into Clinical Trial Services Agreement with PeriNess Ltd. to Accelerate Development of DNase I Oncology Program |
Check out Xenetic Biosciences Backtesting, Xenetic Biosciences Valuation, Xenetic Biosciences Correlation, Xenetic Biosciences Hype Analysis, Xenetic Biosciences Volatility, Xenetic Biosciences History as well as Xenetic Biosciences Performance. To learn how to invest in Xenetic Stock, please use our How to Invest in Xenetic Biosciences guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xenetic Biosciences. If investors know Xenetic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xenetic Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.66) | Revenue Per Share 1.638 | Quarterly Revenue Growth 0.116 | Return On Assets (0.29) | Return On Equity (0.49) |
The market value of Xenetic Biosciences is measured differently than its book value, which is the value of Xenetic that is recorded on the company's balance sheet. Investors also form their own opinion of Xenetic Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Xenetic Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xenetic Biosciences' market value can be influenced by many factors that don't directly affect Xenetic Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xenetic Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Xenetic Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xenetic Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.